As it happened: FTSE 100 hits new high after interest rates held Markets Welcome back to the Morning Wire liveblog. The Bank of England has held interest rates at 3.75 per cent in a 6-3 split. The City had pencilled in a hawkish hold from the Monetary Policy Committee after inflationary pressures were renewed on the latest round of strikes in the Middle East. Megan Greene, Catherine Mann and [...]
Haleon takes hit from ‘weak cold and flu season’ but Sensodyne shines Retail After being spun out from GSK in the biggest London IPO in decades, City analyst are looking for more from the emblematic FTSE 100 consumer healthcare powerhouse with roots in a Lombard Street apothecary shop Fewer sniffles during the winter have sent a chill through sales volumes at Haleon, the FTSE 100 over-the-counter remedy maker. [...]
Haleon launches buyback and hikes dividend after strong year healthcare Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five per cent. However, revenue declined by 0.6 per cent on a reported basis to £11.2bn, while adjusted operating profit increased 9.8 per cent to £2.5bn. Haleon focuses on over-the-counter medicines, oral health, and vitamins, minerals and supplements. [...]
Sensodyne and ‘power brands’ help Haleon grow revenue and profit October 31, 2024 Consumer healthcare company Haleon has reported growth across all its categories and regions in its third quarter amid healthy toothpaste and mouthwash sales. In the three months ended 30 September, 2024, it achieved organic revenue and organic profit growth of 6.1 per cent and 7.4 per cent, respectively, off the back of strong sales of its [...]
Haleon posts profit bump on back of power brands August 1, 2024 Consumer healthcare company Haleon has reported mid-single-digit growth amid strong demand for its power brands despite a soft market.
Haleon: Sensodyne maker strikes £500m deal to sell major division June 26, 2024 Haleon, the maker of Sensodyne toothpaste, has agreed a £500m deal to sell a major division outside of the US.
Haleon posts healthy first quarter update after UK job cuts May 1, 2024 Revenue at Haleon was up in the first quarter despite its announcement yesterday that it would cut over 400 jobs in the UK, as the consumer healthcare firm posted a quarterly update in line with expectations.
Sensodyne maker Haleon to cut over 400 jobs and close its only UK factory April 30, 2024 The maker of Sensodyne toothpaste and Advil painkillers has announced plans to close its only UK factory which will see the loss of more than 400 jobs.
Panadol painkiller-maker Haleon to buy shares from Pfizer as US pharma giant slims stake March 18, 2024 fizer has committed to sell down its stake in a "slow and methodical" manner over time.
Haleon reports single-digit growth in revenue after year of disposals February 29, 2024 Its revenue went up by four per cent from £10.8bn reported in 2022, as the company's adjusted operating profit had a healthy growth of 10.4 per cent, at constant currency to £2.5bn.